Asan Medical Center

Public research footprint of Asan Medical Center, compiled from the ClinicalTrials.gov public registry.

2,713

Registered studies

822

Active

439

Recruiting now

1,314

Completed

292

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · Resectable Pancreatic Ductal Adenocarcinoma (PDAC) · Recurrent Endometrial Clear Cell Adenocarcinoma

Recently updated registry entries

NCT05663866 — Premedication to Reduce Amivantamab Associated Infusion Related Reactions (Active Not Recruiting)
NCT05488314 — A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic… (Active Not Recruiting)
NCT03767244 — A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Asan Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.